Thursday, November 1, 2018

Strides Pharma Q2 net loss at Rs 87 million on poor operating income

Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion

from Today's Paper https://ift.tt/2Oi8TlM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)